BR0312814A - Levamisol / avermectinas ou similares em solvente de pirrolidona - Google Patents
Levamisol / avermectinas ou similares em solvente de pirrolidonaInfo
- Publication number
- BR0312814A BR0312814A BR0312814-8A BR0312814A BR0312814A BR 0312814 A BR0312814 A BR 0312814A BR 0312814 A BR0312814 A BR 0312814A BR 0312814 A BR0312814 A BR 0312814A
- Authority
- BR
- Brazil
- Prior art keywords
- levamisol
- avermectins
- pyrrolidone solvent
- solvent
- pyrrolidone
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Tropical Medicine & Parasitology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Saccharide Compounds (AREA)
Abstract
"LEVAMISOL/AVERMECTINAS OU SIMILARES EM SOLVENTE DE PIRROLIDONA". A presente invenção refere-se a uma formulação estável, que é adequada para administração a animais. A formulação inclui pelo menos uma substância ativa, selecionada do grupo compreendendo avermectinas e milbemicina e levamisol. Ambas as ditas substâncias ativas são dissolvidas em um solvente de pirrolidona.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NZ520295A NZ520295A (en) | 2002-07-19 | 2002-07-19 | Anthelmintic formulations comprising levamisole and either an avermectin or milbemycin |
PCT/NZ2003/000157 WO2004009080A1 (en) | 2002-07-19 | 2003-07-21 | Levamisole, Avermectins or similar in pyrrolidone solvent |
Publications (2)
Publication Number | Publication Date |
---|---|
BR0312814A true BR0312814A (pt) | 2005-04-19 |
BRPI0312814B1 BRPI0312814B1 (pt) | 2017-06-06 |
Family
ID=30768277
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0312814A BRPI0312814B1 (pt) | 2002-07-19 | 2003-07-21 | levamisol / avermectinas ou similares em solvente de pirrolidona |
Country Status (8)
Country | Link |
---|---|
US (1) | US20060128641A1 (pt) |
EP (1) | EP1551390B1 (pt) |
AU (2) | AU2003281472B2 (pt) |
BR (1) | BRPI0312814B1 (pt) |
DK (1) | DK1551390T3 (pt) |
NZ (1) | NZ520295A (pt) |
SI (1) | SI1551390T1 (pt) |
WO (1) | WO2004009080A1 (pt) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
UA82359C2 (uk) * | 2003-04-03 | 2008-04-10 | Schering Plough Ltd | Композиція (варіанти) і спосіб лікування мікробних і паразитних інфекцій у великої рогатої худоби і інших тварин |
WO2006027745A2 (en) * | 2004-09-09 | 2006-03-16 | Warburton Technology Limited | Trace elements |
EP1875423A4 (en) | 2005-04-29 | 2011-10-05 | Mercatus Technologies Inc | SYSTEMS AND METHODS FOR INFORMATION MANAGEMENT INTEGRATING AN INDIVIDUAL COMPUTING DEVICE |
AR056808A1 (es) * | 2005-11-18 | 2007-10-24 | Cheminova As | Formulacion de aceite en agua de avermectinas |
BRPI0506279B1 (pt) | 2005-12-16 | 2018-01-09 | Npa - Núcleo De Pesquisas Aplicadas Ltda | Composição sinergística de antihelmínticos e endectocidas |
NZ552040A (en) * | 2006-12-13 | 2009-04-30 | Bomac Research Ltd | Veterinary formulation comprising an anthelmintic compound and glyceryl acetate |
AU2013201461B2 (en) * | 2007-11-26 | 2015-10-29 | Boehringer Ingelheim Animal Health USA Inc. | Solvent systems for pour-on formulations for combating parasites |
DK2222168T3 (en) * | 2007-11-26 | 2018-12-03 | Merial Inc | SOLUTION SYSTEMS FOR POUR-ON FORMULAS TO FIGHT PARASITES |
UA108641C2 (uk) | 2010-04-02 | 2015-05-25 | Паразитицидна композиція, яка містить чотири активних агенти, та спосіб її застосування | |
PT2568980E (pt) * | 2010-05-12 | 2016-03-15 | Merial Inc | Formulações parasiticidas injectáveis de levamisole e lactonas macrocíclicas |
AU2016201743B2 (en) * | 2010-05-12 | 2017-10-19 | Boehringer Ingelheim Animal Health USA Inc. | Injectable parasiticidal formulations of levamisole and macrocyclic lactones |
AR081970A1 (es) * | 2010-06-24 | 2012-10-31 | Intervet Int Bv | Formulacion inyectable de una lactona macrociclica y levamisol, formulacion y uso veterinario |
NZ612185A (en) | 2010-12-07 | 2015-10-30 | Merial Inc | Topical combination formulations of macrocyclic lactones with synthetic pyrethroids |
JP6120834B2 (ja) | 2011-06-23 | 2017-04-26 | バイエル・ニュージーランド・リミテッド | 大環状ラクトンおよびレバミゾールを含む抗寄生生物性組成物、ならびに寄生生物感染の処置方法 |
NZ594610A (en) | 2011-08-16 | 2013-03-28 | Virbac New Zealand Ltd | Injectable Anthelmintic Formulations cotaining levamisole and one or more macrocyclic lactones for controlling internal parasites in ruminants |
US11583545B2 (en) | 2018-02-08 | 2023-02-21 | Boehringer Ingelheim Animal Health USA Inc. | Parasiticidal compositions comprising eprinomectin and praziquantel, methods and uses thereof |
AU2020208145B2 (en) * | 2019-01-16 | 2023-02-02 | Boehringer Ingelheim Vetmedica Gmbh | Topical compositions comprising a neonicotinoid and a macrocyclic lactone, methods and uses thereof |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5773422A (en) * | 1996-01-29 | 1998-06-30 | Komer; Gene | Avermectin formulation |
EP0959891A1 (en) * | 1996-07-30 | 1999-12-01 | Ashmont Holdings Limited | Anthelmintic formulations |
US6426333B1 (en) * | 1996-09-19 | 2002-07-30 | Merial | Spot-on formulations for combating parasites |
ZA981925B (en) * | 1997-03-21 | 1998-10-23 | Biogenesis S A | A long acting injectable parasiticidal composition and the process for its preparation |
EP1182931B1 (en) * | 1999-06-04 | 2005-12-28 | Nufarm Limited | Stable biocidal compositions |
US6780885B1 (en) * | 2000-01-14 | 2004-08-24 | Idexx Laboratories, Inc. | Formulations and methods for administration of pharmacologically or biologically active compounds |
US6340672B1 (en) * | 2000-02-16 | 2002-01-22 | Phoenix Scientific, Inc. | Parasiticidal formulation and a method of making this formulation |
-
2002
- 2002-07-19 NZ NZ520295A patent/NZ520295A/en not_active IP Right Cessation
-
2003
- 2003-07-21 AU AU2003281472A patent/AU2003281472B2/en not_active Expired
- 2003-07-21 DK DK03741701.1T patent/DK1551390T3/da active
- 2003-07-21 WO PCT/NZ2003/000157 patent/WO2004009080A1/en not_active Application Discontinuation
- 2003-07-21 SI SI200332354T patent/SI1551390T1/sl unknown
- 2003-07-21 US US10/521,604 patent/US20060128641A1/en not_active Abandoned
- 2003-07-21 EP EP03741701.1A patent/EP1551390B1/en not_active Expired - Lifetime
- 2003-07-21 BR BRPI0312814A patent/BRPI0312814B1/pt active IP Right Grant
-
2005
- 2005-01-11 AU AU2005200099A patent/AU2005200099A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP1551390A1 (en) | 2005-07-13 |
WO2004009080A1 (en) | 2004-01-29 |
DK1551390T3 (da) | 2014-04-28 |
EP1551390B1 (en) | 2014-04-02 |
BRPI0312814B1 (pt) | 2017-06-06 |
AU2005200099A1 (en) | 2005-03-17 |
AU2003281472B2 (en) | 2008-07-24 |
SI1551390T1 (sl) | 2014-07-31 |
EP1551390A4 (en) | 2008-11-05 |
NZ520295A (en) | 2005-04-29 |
AU2003281472A1 (en) | 2004-02-09 |
US20060128641A1 (en) | 2006-06-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0312814A (pt) | Levamisol / avermectinas ou similares em solvente de pirrolidona | |
BRPI0409185A (pt) | formulações veterinárias anti-helmìnticas tópicas | |
BR0107246A (pt) | Agentes diazabicìclicos ativos no sistema nervoso central | |
DK1345611T3 (da) | Antibiotisk/analgetisk formulering og en fremgangsmåde til fremstilling deraf | |
DK1299108T3 (da) | Parasiticidt præparat samt fremgangsmåde til fremstilling af dette præparat | |
BRPI0418098A (pt) | formulações veterinárias não contendo produtos animais | |
HN2000000267A (es) | Oxazolidinonas substituidas y su uso | |
DE69926386D1 (de) | Propofol-formulierung | |
BR0313060A (pt) | Composições farmacêuticas aquosas de 2,6-diisopropilfenol | |
ATE380023T1 (de) | Orale feste pharmazeutische zusammensetzungen zur ph-abhängig mehrphasigen freisetzung | |
CL2003002277A1 (es) | Composicion farmaceutica inyectable, de deposito de liberacion prolongada, que comprende un agente beneficioso disuelto o disperso en un gel constituido por un polimero bioerosionable y biocompatible; y un solvente. | |
BRPI0416038A (pt) | gel baseado em tensoativo como um veìculo injetável de liberação sustentada de droga | |
NO20016107D0 (no) | Mesalazin-kontrollert frigivelse orale farmasöytiske sammensetninger | |
BRPI0412975A (pt) | espuma penetrante para uso farmacêutico | |
BRPI0408925A (pt) | veìculos de fase simples não-aquosos e formulações utilizando tais veìculos | |
BRPI0113286B8 (pt) | pirazóis substituídos e composição farmacêutica compreendendo os mesmos. | |
BRPI0409133A (pt) | formulações farmacêuticas contendo metilnaltrexona | |
DE60313597D1 (de) | Topische pharmazeutische zusammensetzungen mit proanthocyanidinen, glycyrrhetinic säure und telmesteine zur behandlung von dermatitis | |
ITMI20021392A1 (it) | Forme farmaceutiche per la somministrazione orale di farmaci liquidi a temperatura ambiente dotate di migliore biodisponibilita' | |
PT1318791E (pt) | Composicao farmaceutica semi-solida de isotretinoina | |
WO1999055332A8 (fr) | Compositions medicinales | |
GT199800207A (es) | Nuevos derivados de la eritromicina. | |
DE60231862D1 (de) | Erodierbare polymere zur injektion | |
IS8430A (is) | Lyf sem inniheldur (2R)-2-própýloktansýru sem virka efnisþáttinn | |
DE50311778D1 (de) | Mischsystem zur löslichkeitsvermittlung von pharmazeutischen wirkstoffen in polymermatrizes |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B25A | Requested transfer of rights approved |
Owner name: MERIAL LIMITED (GB) Free format text: TRANSFERIDO DE: ASHMONT HOLDINGS LIMITED |
|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B07G | Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette] |
Free format text: NOTIFICACAO DE DEVOLUCAO DO PEDIDO POR NAO SE ENQUADRAR NO ART. 229-C DA LPI. |
|
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: INDEFIRO O PEDIDO DE ACORDO COM OS ARTIGOS 8O, 11 E 13 DA LPI. |
|
B12B | Appeal against refusal [chapter 12.2 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] | ||
B25G | Requested change of headquarter approved | ||
B25A | Requested transfer of rights approved | ||
B25A | Requested transfer of rights approved |